

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | musculoskeletal movement (GO:0050881) | 9.60309443 |
| 2 | multicellular organismal movement (GO:0050879) | 9.60309443 |
| 3 | myotube cell development (GO:0014904) | 9.25845046 |
| 4 | myoblast fusion (GO:0007520) | 9.17319048 |
| 5 | muscle cell fate commitment (GO:0042693) | 8.69639624 |
| 6 | syncytium formation by plasma membrane fusion (GO:0000768) | 8.32106155 |
| 7 | lens development in camera-type eye (GO:0002088) | 8.29202403 |
| 8 | syncytium formation (GO:0006949) | 8.01220412 |
| 9 | positive regulation of myotube differentiation (GO:0010831) | 7.84838741 |
| 10 | actin filament-based movement (GO:0030048) | 7.84339981 |
| 11 | plasma membrane repair (GO:0001778) | 7.54802072 |
| 12 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.27463036 |
| 13 | muscle cell cellular homeostasis (GO:0046716) | 7.06737151 |
| 14 | positive regulation of skeletal muscle tissue development (GO:0048643) | 6.75953931 |
| 15 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.51694028 |
| 16 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 6.43961856 |
| 17 | response to inactivity (GO:0014854) | 6.24968596 |
| 18 | skeletal muscle tissue development (GO:0007519) | 6.14678734 |
| 19 | lens fiber cell development (GO:0070307) | 6.03210906 |
| 20 | regulation of skeletal muscle contraction (GO:0014819) | 5.98140266 |
| 21 | sarcomere organization (GO:0045214) | 5.87785397 |
| 22 | response to muscle activity (GO:0014850) | 5.85750737 |
| 23 | muscle fiber development (GO:0048747) | 5.83534846 |
| 24 | plasma membrane fusion (GO:0045026) | 5.77959635 |
| 25 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.64703831 |
| 26 | striated muscle atrophy (GO:0014891) | 5.54183402 |
| 27 | regulation of relaxation of muscle (GO:1901077) | 5.53554004 |
| 28 | muscle organ development (GO:0007517) | 5.45147871 |
| 29 | striated muscle contraction (GO:0006941) | 5.38667270 |
| 30 | muscle structure development (GO:0061061) | 5.30227512 |
| 31 | lens fiber cell differentiation (GO:0070306) | 5.21858031 |
| 32 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 5.20762885 |
| 33 | regulation of skeletal muscle cell differentiation (GO:2001014) | 5.18520235 |
| 34 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.15669685 |
| 35 | negative regulation of cell size (GO:0045792) | 4.84913295 |
| 36 | * muscle contraction (GO:0006936) | 4.75506550 |
| 37 | positive regulation of myoblast differentiation (GO:0045663) | 4.73963413 |
| 38 | myofibril assembly (GO:0030239) | 4.72498429 |
| 39 | muscle atrophy (GO:0014889) | 4.71507183 |
| 40 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.60917910 |
| 41 | striated muscle cell development (GO:0055002) | 4.52291978 |
| 42 | actomyosin structure organization (GO:0031032) | 4.34610965 |
| 43 | endodermal cell differentiation (GO:0035987) | 4.28375396 |
| 44 | * muscle system process (GO:0003012) | 4.22297802 |
| 45 | heterotypic cell-cell adhesion (GO:0034113) | 4.20566585 |
| 46 | neuromuscular synaptic transmission (GO:0007274) | 4.17965618 |
| 47 | striated muscle tissue development (GO:0014706) | 4.16025813 |
| 48 | regulation of myotube differentiation (GO:0010830) | 4.13301721 |
| 49 | creatine metabolic process (GO:0006600) | 4.09126133 |
| 50 | negative regulation of protein localization to cell surface (GO:2000009) | 4.07655775 |
| 51 | regulation of myoblast differentiation (GO:0045661) | 4.06090395 |
| 52 | muscle cell development (GO:0055001) | 4.01188972 |
| 53 | myotube differentiation (GO:0014902) | 3.95541231 |
| 54 | muscle adaptation (GO:0043500) | 3.86713594 |
| 55 | neuromuscular junction development (GO:0007528) | 3.80766446 |
| 56 | lens morphogenesis in camera-type eye (GO:0002089) | 3.72871011 |
| 57 | muscle tissue development (GO:0060537) | 3.70670615 |
| 58 | embryonic camera-type eye development (GO:0031076) | 3.68954308 |
| 59 | regulation of striated muscle contraction (GO:0006942) | 3.63733731 |
| 60 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.52878455 |
| 61 | positive regulation of striated muscle cell differentiation (GO:0051155) | 3.50951965 |
| 62 | response to lithium ion (GO:0010226) | 3.47859125 |
| 63 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.47809668 |
| 64 | regulation of p38MAPK cascade (GO:1900744) | 3.46312572 |
| 65 | cellular response to estradiol stimulus (GO:0071392) | 3.39965854 |
| 66 | muscle tissue morphogenesis (GO:0060415) | 3.37337530 |
| 67 | positive regulation of muscle cell differentiation (GO:0051149) | 3.35448671 |
| 68 | regulation of actin filament-based movement (GO:1903115) | 3.33681788 |
| 69 | response to activity (GO:0014823) | 3.31351232 |
| 70 | cardiac muscle hypertrophy (GO:0003300) | 3.30867411 |
| 71 | regulation of skeletal muscle fiber development (GO:0048742) | 3.29203554 |
| 72 | regulation of muscle system process (GO:0090257) | 3.27397939 |
| 73 | glycogen biosynthetic process (GO:0005978) | 3.25875218 |
| 74 | glucan biosynthetic process (GO:0009250) | 3.25875218 |
| 75 | striated muscle adaptation (GO:0014888) | 3.20901448 |
| 76 | positive regulation of astrocyte differentiation (GO:0048711) | 3.17966687 |
| 77 | regulation of skeletal muscle tissue development (GO:0048641) | 3.17621061 |
| 78 | glycogen catabolic process (GO:0005980) | 3.15826026 |
| 79 | response to caffeine (GO:0031000) | 3.15115575 |
| 80 | skeletal muscle tissue regeneration (GO:0043403) | 3.14038738 |
| 81 | striated muscle hypertrophy (GO:0014897) | 3.13183604 |
| 82 | cardiac myofibril assembly (GO:0055003) | 3.12443356 |
| 83 | face morphogenesis (GO:0060325) | 3.10389479 |
| 84 | regulation of muscle contraction (GO:0006937) | 3.06098491 |
| 85 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.05398975 |
| 86 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.05398975 |
| 87 | regulation of sarcomere organization (GO:0060297) | 3.02589656 |
| 88 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.98254319 |
| 89 | postsynaptic membrane organization (GO:0001941) | 2.96876351 |
| 90 | myelin assembly (GO:0032288) | 2.96081270 |
| 91 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.95000706 |
| 92 | glucan catabolic process (GO:0009251) | 2.93704785 |
| 93 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.92523975 |
| 94 | regulation of cell communication by electrical coupling (GO:0010649) | 2.91998073 |
| 95 | synaptic transmission, cholinergic (GO:0007271) | 2.90148735 |
| 96 | skeletal muscle cell differentiation (GO:0035914) | 2.89352409 |
| 97 | regulation of muscle cell differentiation (GO:0051147) | 2.87888961 |
| 98 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.83291534 |
| 99 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.82163138 |
| 100 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.79706769 |
| 101 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.79613834 |
| 102 | skeletal muscle adaptation (GO:0043501) | 2.79226621 |
| 103 | regulation of striated muscle cell differentiation (GO:0051153) | 2.79192451 |
| 104 | basement membrane organization (GO:0071711) | 2.78736904 |
| 105 | cardiac muscle contraction (GO:0060048) | 2.77476474 |
| 106 | glycoprotein catabolic process (GO:0006516) | 2.76633395 |
| 107 | muscle hypertrophy (GO:0014896) | 2.75648286 |
| 108 | positive regulation of p38MAPK cascade (GO:1900745) | 2.75234599 |
| 109 | epithelial cell-cell adhesion (GO:0090136) | 2.75092710 |
| 110 | muscle organ morphogenesis (GO:0048644) | 2.74261589 |
| 111 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.71901704 |
| 112 | membrane tubulation (GO:0097320) | 2.69842905 |
| 113 | cellular polysaccharide catabolic process (GO:0044247) | 2.69778985 |
| 114 | mRNA transcription (GO:0009299) | 2.68214347 |
| 115 | response to parathyroid hormone (GO:0071107) | 2.65231081 |
| 116 | camera-type eye development (GO:0043010) | 2.63206263 |
| 117 | cardiac muscle cell development (GO:0055013) | 2.57944834 |
| 118 | cellular response to osmotic stress (GO:0071470) | 2.53155808 |
| 119 | regulation of membrane repolarization (GO:0060306) | 2.52031272 |
| 120 | positive regulation of protein depolymerization (GO:1901881) | 2.51009622 |
| 121 | cardiac cell development (GO:0055006) | 2.50805263 |
| 122 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.50546634 |
| 123 | collagen fibril organization (GO:0030199) | 2.48278249 |
| 124 | muscle filament sliding (GO:0030049) | 12.1797144 |
| 125 | actin-myosin filament sliding (GO:0033275) | 12.1797144 |
| 126 | skeletal muscle fiber development (GO:0048741) | 11.1087877 |
| 127 | skeletal muscle contraction (GO:0003009) | 10.7760125 |
| 128 | actin-mediated cell contraction (GO:0070252) | 10.1322137 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.75515844 |
| 2 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 3.75015131 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.56059857 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.50747565 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.32549105 |
| 6 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.29122871 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.05119757 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.02838381 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.99447219 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.94917230 |
| 11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.72228447 |
| 12 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.69188254 |
| 13 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.65533298 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.62366147 |
| 15 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.58422153 |
| 16 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.35076239 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.11587765 |
| 18 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.06855230 |
| 19 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 2.04063404 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.03934697 |
| 21 | P68_20966046_ChIP-Seq_HELA_Human | 2.01138374 |
| 22 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.00707456 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.98186481 |
| 24 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.97438289 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.91082190 |
| 26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.90117723 |
| 27 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.87246585 |
| 28 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.81534210 |
| 29 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.81061587 |
| 30 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.75322371 |
| 31 | * MAF_26560356_Chip-Seq_TH2_Human | 1.75290835 |
| 32 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.73699649 |
| 33 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.73699649 |
| 34 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.68821826 |
| 35 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.67460701 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.65403252 |
| 37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.64797480 |
| 38 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.63390149 |
| 39 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.61917618 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.60860877 |
| 41 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.59564019 |
| 42 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.59502810 |
| 43 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.59306032 |
| 44 | CJUN_26792858_Chip-Seq_BT549_Human | 1.59012672 |
| 45 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.58133730 |
| 46 | ATF3_27146783_Chip-Seq_COLON_Human | 1.57947977 |
| 47 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.56383288 |
| 48 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.55254574 |
| 49 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.54782711 |
| 50 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.53887158 |
| 51 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.52474504 |
| 52 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.51181352 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.50617274 |
| 54 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.50351699 |
| 55 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.49849221 |
| 56 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.49609687 |
| 57 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.48468669 |
| 58 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.47927631 |
| 59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.47345482 |
| 60 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.45879022 |
| 61 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.41803369 |
| 62 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.41737946 |
| 63 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.41344189 |
| 64 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.40065039 |
| 65 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39442436 |
| 66 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.39211133 |
| 67 | KDM2B_26808549_Chip-Seq_K562_Human | 1.38099259 |
| 68 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.32951938 |
| 69 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.31008861 |
| 70 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30914649 |
| 71 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.30747727 |
| 72 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.30600014 |
| 73 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.30463993 |
| 74 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28810834 |
| 75 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.28750572 |
| 76 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.28389526 |
| 77 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.27198196 |
| 78 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.25475701 |
| 79 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.24773401 |
| 80 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.24773401 |
| 81 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24297673 |
| 82 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.23399121 |
| 83 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.23090151 |
| 84 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.22994722 |
| 85 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.21023671 |
| 86 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.20616384 |
| 87 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.20301726 |
| 88 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20269921 |
| 89 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.20131669 |
| 90 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.19695919 |
| 91 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.19141819 |
| 92 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.18740103 |
| 93 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.17129393 |
| 94 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.15402836 |
| 95 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.15264545 |
| 96 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15174340 |
| 97 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14871876 |
| 98 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.14781926 |
| 99 | MYC_22102868_ChIP-Seq_BL_Human | 1.14399272 |
| 100 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13299949 |
| 101 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12951015 |
| 102 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.12279118 |
| 103 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.12267358 |
| 104 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09946052 |
| 105 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.09761471 |
| 106 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08656473 |
| 107 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.08583274 |
| 108 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08238301 |
| 109 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07775054 |
| 110 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.07622459 |
| 111 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06494808 |
| 112 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.05968686 |
| 113 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.05615970 |
| 114 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04521412 |
| 115 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.04253082 |
| 116 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.03874587 |
| 117 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.03397631 |
| 118 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.02139067 |
| 119 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.02103433 |
| 120 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02093298 |
| 121 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.01459820 |
| 122 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.00640647 |
| 123 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00487508 |
| 124 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00267223 |
| 125 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.00223875 |
| 126 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.99977422 |
| 127 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.99268770 |
| 128 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.98492098 |
| 129 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97393225 |
| 130 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96692975 |
| 131 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96580657 |
| 132 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96438716 |
| 133 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.95752055 |
| 134 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95615292 |
| 135 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94924867 |
| 136 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.94732592 |
| 137 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.94724776 |
| 138 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.94567851 |
| 139 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.94131703 |
| 140 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93917856 |
| 141 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.93172962 |
| 142 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92404080 |
| 143 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92089586 |
| 144 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.91131735 |
| 145 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.91017631 |
| 146 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.84348227 |
| 147 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84327990 |
| 148 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83463432 |
| 149 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83367017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000749_muscle_degeneration | 7.56016380 |
| 2 | MP0000751_myopathy | 6.64728304 |
| 3 | MP0000733_abnormal_muscle_development | 4.66690329 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 4.45672385 |
| 5 | MP0000750_abnormal_muscle_regeneration | 4.17686835 |
| 6 | MP0000747_muscle_weakness | 3.95098495 |
| 7 | * MP0002106_abnormal_muscle_physiology | 3.51230173 |
| 8 | MP0004270_analgesia | 3.40292828 |
| 9 | MP0002269_muscular_atrophy | 3.37435127 |
| 10 | * MP0000759_abnormal_skeletal_muscle | 3.32642784 |
| 11 | * MP0004087_abnormal_muscle_fiber | 3.29215111 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 3.14490271 |
| 13 | MP0002697_abnormal_eye_size | 3.08304293 |
| 14 | * MP0005369_muscle_phenotype | 3.00661585 |
| 15 | MP0002108_abnormal_muscle_morphology | 2.42743759 |
| 16 | MP0004233_abnormal_muscle_weight | 2.42102239 |
| 17 | MP0002249_abnormal_larynx_morphology | 2.26327818 |
| 18 | MP0004084_abnormal_cardiac_muscle | 2.14375312 |
| 19 | MP0010030_abnormal_orbit_morphology | 2.13916756 |
| 20 | MP0005193_abnormal_anterior_eye | 2.08224789 |
| 21 | MP0005330_cardiomyopathy | 1.95558067 |
| 22 | MP0005171_absent_coat_pigmentation | 1.94557277 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 1.93062253 |
| 24 | MP0005451_abnormal_body_composition | 1.90771888 |
| 25 | MP0001661_extended_life_span | 1.86183907 |
| 26 | MP0003950_abnormal_plasma_membrane | 1.78602581 |
| 27 | MP0002971_abnormal_brown_adipose | 1.74171626 |
| 28 | MP0005623_abnormal_meninges_morphology | 1.71636959 |
| 29 | MP0003941_abnormal_skin_development | 1.70474466 |
| 30 | MP0004036_abnormal_muscle_relaxation | 1.66651219 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.61256939 |
| 32 | MP0005423_abnormal_somatic_nervous | 1.59370901 |
| 33 | MP0005620_abnormal_muscle_contractility | 1.58708041 |
| 34 | MP0000767_abnormal_smooth_muscle | 1.46796063 |
| 35 | MP0001542_abnormal_bone_strength | 1.42823374 |
| 36 | MP0001346_abnormal_lacrimal_gland | 1.42758633 |
| 37 | MP0001299_abnormal_eye_distance/ | 1.38928305 |
| 38 | MP0003279_aneurysm | 1.28726909 |
| 39 | MP0004215_abnormal_myocardial_fiber | 1.26118239 |
| 40 | MP0010630_abnormal_cardiac_muscle | 1.25565128 |
| 41 | MP0005083_abnormal_biliary_tract | 1.17510317 |
| 42 | MP0009250_abnormal_appendicular_skeleto | 1.11830488 |
| 43 | MP0005503_abnormal_tendon_morphology | 1.11092277 |
| 44 | MP0001915_intracranial_hemorrhage | 1.10775409 |
| 45 | MP0003566_abnormal_cell_adhesion | 1.09905019 |
| 46 | MP0004272_abnormal_basement_membrane | 1.08490634 |
| 47 | MP0003646_muscle_fatigue | 1.05129086 |
| 48 | MP0003136_yellow_coat_color | 1.04313727 |
| 49 | MP0003705_abnormal_hypodermis_morpholog | 1.03397195 |
| 50 | MP0005197_abnormal_uvea_morphology | 1.02589107 |
| 51 | MP0002114_abnormal_axial_skeleton | 1.02103333 |
| 52 | MP0002877_abnormal_melanocyte_morpholog | 1.01374872 |
| 53 | MP0003879_abnormal_hair_cell | 1.00308353 |
| 54 | MP0002972_abnormal_cardiac_muscle | 0.99249209 |
| 55 | MP0002234_abnormal_pharynx_morphology | 0.98959944 |
| 56 | MP0003091_abnormal_cell_migration | 0.94810468 |
| 57 | MP0000013_abnormal_adipose_tissue | 0.94478903 |
| 58 | MP0003385_abnormal_body_wall | 0.93313225 |
| 59 | MP0005266_abnormal_metabolism | 0.90887529 |
| 60 | MP0002734_abnormal_mechanical_nocicepti | 0.89033518 |
| 61 | MP0005248_abnormal_Harderian_gland | 0.87224542 |
| 62 | MP0001958_emphysema | 0.87074785 |
| 63 | MP0002127_abnormal_cardiovascular_syste | 0.86864390 |
| 64 | MP0003942_abnormal_urinary_system | 0.84425365 |
| 65 | MP0005409_darkened_coat_color | 0.83451602 |
| 66 | MP0001286_abnormal_eye_development | 0.83349347 |
| 67 | MP0005275_abnormal_skin_tensile | 0.79825677 |
| 68 | MP0005367_renal/urinary_system_phenotyp | 0.77975320 |
| 69 | MP0000516_abnormal_urinary_system | 0.77975320 |
| 70 | MP0005508_abnormal_skeleton_morphology | 0.77260037 |
| 71 | MP0004134_abnormal_chest_morphology | 0.75236041 |
| 72 | MP0003755_abnormal_palate_morphology | 0.74965167 |
| 73 | MP0004197_abnormal_fetal_growth/weight/ | 0.74647057 |
| 74 | MP0009384_cardiac_valve_regurgitation | 0.73286506 |
| 75 | MP0006036_abnormal_mitochondrial_physio | 0.73112813 |
| 76 | MP0002932_abnormal_joint_morphology | 0.71527592 |
| 77 | MP0009780_abnormal_chondrocyte_physiolo | 0.70619914 |
| 78 | MP0005257_abnormal_intraocular_pressure | 0.70015333 |
| 79 | MP0005174_abnormal_tail_pigmentation | 0.69593288 |
| 80 | MP0001440_abnormal_grooming_behavior | 0.68699535 |
| 81 | MP0000858_altered_metastatic_potential | 0.67584596 |
| 82 | MP0005375_adipose_tissue_phenotype | 0.67047860 |
| 83 | MP0003115_abnormal_respiratory_system | 0.64950611 |
| 84 | MP0000049_abnormal_middle_ear | 0.64929627 |
| 85 | MP0008569_lethality_at_weaning | 0.61850681 |
| 86 | MP0004185_abnormal_adipocyte_glucose | 0.61314622 |
| 87 | MP0003045_fibrosis | 0.60995461 |
| 88 | MP0005076_abnormal_cell_differentiation | 0.60956354 |
| 89 | MP0002092_abnormal_eye_morphology | 0.60731826 |
| 90 | MP0000762_abnormal_tongue_morphology | 0.60390172 |
| 91 | MP0000003_abnormal_adipose_tissue | 0.59163493 |
| 92 | MP0003221_abnormal_cardiomyocyte_apopto | 0.58362845 |
| 93 | MP0004510_myositis | 0.57341629 |
| 94 | MP0002896_abnormal_bone_mineralization | 0.55971229 |
| 95 | MP0004858_abnormal_nervous_system | 0.55460804 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.54443172 |
| 97 | MP0003283_abnormal_digestive_organ | 0.54130617 |
| 98 | MP0002933_joint_inflammation | 0.53243468 |
| 99 | MP0004484_altered_response_of | 0.53063797 |
| 100 | MP0006138_congestive_heart_failure | 0.52181989 |
| 101 | MP0000428_abnormal_craniofacial_morphol | 0.51082650 |
| 102 | MP0002332_abnormal_exercise_endurance | 0.47713116 |
| 103 | MP0002128_abnormal_blood_circulation | 0.47131018 |
| 104 | MP0002160_abnormal_reproductive_system | 0.47090763 |
| 105 | MP0000266_abnormal_heart_morphology | 0.46557470 |
| 106 | MP0000163_abnormal_cartilage_morphology | 0.45451713 |
| 107 | * MP0001943_abnormal_respiration | 0.44504355 |
| 108 | MP0003828_pulmonary_edema | 0.43617927 |
| 109 | MP0005023_abnormal_wound_healing | 0.43302196 |
| 110 | MP0002638_abnormal_pupillary_reflex | 0.42745709 |
| 111 | MP0001614_abnormal_blood_vessel | 0.42439845 |
| 112 | MP0000534_abnormal_ureter_morphology | 0.40704166 |
| 113 | MP0004130_abnormal_muscle_cell | 0.40336036 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.40210312 |
| 115 | MP0005501_abnormal_skin_physiology | 0.39947050 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.39878980 |
| 117 | MP0000432_abnormal_head_morphology | 0.38505108 |
| 118 | MP0004085_abnormal_heartbeat | 0.38475851 |
| 119 | MP0002116_abnormal_craniofacial_bone | 0.38040672 |
| 120 | MP0008775_abnormal_heart_ventricle | 0.36712564 |
| 121 | * MP0002081_perinatal_lethality | 0.36612877 |
| 122 | MP0002113_abnormal_skeleton_development | 0.36526561 |
| 123 | MP0001544_abnormal_cardiovascular_syste | 0.36402145 |
| 124 | MP0005385_cardiovascular_system_phenoty | 0.36402145 |
| 125 | MP0005621_abnormal_cell_physiology | 0.36368073 |
| 126 | MP0003959_abnormal_lean_body | 0.35637757 |
| 127 | MP0002060_abnormal_skin_morphology | 0.35041958 |
| 128 | MP0001756_abnormal_urination | 0.33733326 |
| 129 | MP0008770_decreased_survivor_rate | 0.32256479 |
| 130 | MP0006276_abnormal_autonomic_nervous | 0.29740600 |
| 131 | * MP0003948_abnormal_gas_homeostasis | 0.27930600 |
| 132 | MP0002822_catalepsy | 0.27338312 |
| 133 | MP0002163_abnormal_gland_morphology | 0.26798201 |
| 134 | MP0002089_abnormal_postnatal_growth/wei | 0.26401885 |
| 135 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.26013767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 8.11335100 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.06455738 |
| 3 | * Fetal akinesia sequence (HP:0001989) | 7.58363446 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 7.45041799 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 7.38518124 |
| 6 | * Popliteal pterygium (HP:0009756) | 7.34281010 |
| 7 | Nuclear cataract (HP:0100018) | 7.14535189 |
| 8 | Type 2 muscle fiber atrophy (HP:0003554) | 6.52029365 |
| 9 | * Abnormality of placental membranes (HP:0011409) | 6.31881700 |
| 10 | * Amniotic constriction ring (HP:0009775) | 6.31881700 |
| 11 | * Aplasia of the musculature (HP:0100854) | 6.28393586 |
| 12 | Distal arthrogryposis (HP:0005684) | 5.94957906 |
| 13 | Zonular cataract (HP:0010920) | 5.92984900 |
| 14 | Muscle fiber atrophy (HP:0100295) | 5.92614934 |
| 15 | Weak cry (HP:0001612) | 5.72418970 |
| 16 | Abnormality of the neuromuscular junction (HP:0003398) | 5.71452738 |
| 17 | Fatigable weakness (HP:0003473) | 5.71452738 |
| 18 | Round ear (HP:0100830) | 5.65906340 |
| 19 | * Malignant hyperthermia (HP:0002047) | 5.65853195 |
| 20 | Ulnar deviation of the wrist (HP:0003049) | 5.36619456 |
| 21 | Myopathic facies (HP:0002058) | 4.99940797 |
| 22 | * Akinesia (HP:0002304) | 4.91881245 |
| 23 | Bulbar palsy (HP:0001283) | 4.79177370 |
| 24 | Calcaneovalgus deformity (HP:0001848) | 4.75244448 |
| 25 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.48884254 |
| 26 | Gowers sign (HP:0003391) | 4.42622872 |
| 27 | Deformed tarsal bones (HP:0008119) | 4.34979257 |
| 28 | Absent phalangeal crease (HP:0006109) | 3.93461936 |
| 29 | Easy fatigability (HP:0003388) | 3.90266177 |
| 30 | * Thin ribs (HP:0000883) | 3.74933156 |
| 31 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.74456798 |
| 32 | * Pterygium (HP:0001059) | 3.72041504 |
| 33 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.63659942 |
| 34 | * Aplasia/Hypoplasia involving the musculature (HP:0001460) | 3.60250509 |
| 35 | Increased variability in muscle fiber diameter (HP:0003557) | 3.50826925 |
| 36 | EMG: myopathic abnormalities (HP:0003458) | 3.50494243 |
| 37 | Hip contracture (HP:0003273) | 3.43413370 |
| 38 | Slender build (HP:0001533) | 3.42097523 |
| 39 | Generalized muscle weakness (HP:0003324) | 3.41417113 |
| 40 | Abnormal finger flexion creases (HP:0006143) | 3.35221334 |
| 41 | Difficulty climbing stairs (HP:0003551) | 3.30114342 |
| 42 | Abnormality of the calf musculature (HP:0001430) | 3.21022418 |
| 43 | Scapular winging (HP:0003691) | 3.16568746 |
| 44 | * Hypoplastic heart (HP:0001961) | 3.11040837 |
| 45 | Muscle fiber splitting (HP:0003555) | 3.04282542 |
| 46 | Hyporeflexia of lower limbs (HP:0002600) | 3.03221995 |
| 47 | Trismus (HP:0000211) | 3.03185577 |
| 48 | Difficulty running (HP:0009046) | 3.02948776 |
| 49 | Abnormality of the calcaneus (HP:0008364) | 3.01060852 |
| 50 | Neck muscle weakness (HP:0000467) | 2.98710060 |
| 51 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.97269341 |
| 52 | Subaortic stenosis (HP:0001682) | 2.97269341 |
| 53 | * Cystic hygroma (HP:0000476) | 2.94201986 |
| 54 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 2.86763771 |
| 55 | Asymmetric septal hypertrophy (HP:0001670) | 2.73187045 |
| 56 | Poor suck (HP:0002033) | 2.69867107 |
| 57 | Increased connective tissue (HP:0009025) | 2.69075396 |
| 58 | Spinal rigidity (HP:0003306) | 2.65312827 |
| 59 | Distal lower limb amyotrophy (HP:0008944) | 2.58709612 |
| 60 | Breech presentation (HP:0001623) | 2.57332843 |
| 61 | Calf muscle hypertrophy (HP:0008981) | 2.52416867 |
| 62 | Frequent falls (HP:0002359) | 2.52073149 |
| 63 | Infantile muscular hypotonia (HP:0008947) | 2.51516859 |
| 64 | Rhabdomyolysis (HP:0003201) | 2.50206392 |
| 65 | Myoglobinuria (HP:0002913) | 2.41503274 |
| 66 | Limited hip movement (HP:0008800) | 2.39169817 |
| 67 | Muscle stiffness (HP:0003552) | 2.38493428 |
| 68 | Areflexia of lower limbs (HP:0002522) | 2.34009574 |
| 69 | * Abnormalities of placenta or umbilical cord (HP:0001194) | 2.32089084 |
| 70 | Exercise-induced myalgia (HP:0003738) | 2.27402416 |
| 71 | * Diminished movement (HP:0002374) | 2.24915408 |
| 72 | Mask-like facies (HP:0000298) | 2.24830131 |
| 73 | EMG: neuropathic changes (HP:0003445) | 2.22732005 |
| 74 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.22386567 |
| 75 | Chin dimple (HP:0010751) | 2.20047583 |
| 76 | * Arthrogryposis multiplex congenita (HP:0002804) | 2.19144689 |
| 77 | * Webbed neck (HP:0000465) | 2.16856424 |
| 78 | Limb-girdle muscle atrophy (HP:0003797) | 2.13194235 |
| 79 | Metatarsus adductus (HP:0001840) | 2.09851009 |
| 80 | Rimmed vacuoles (HP:0003805) | 2.09340592 |
| 81 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.07692593 |
| 82 | Nonprogressive disorder (HP:0003680) | 1.99506472 |
| 83 | Lower limb amyotrophy (HP:0007210) | 1.98756540 |
| 84 | Thin bony cortex (HP:0002753) | 1.92345122 |
| 85 | Depressed nasal tip (HP:0000437) | 1.90532702 |
| 86 | Congenital hip dislocation (HP:0001374) | 1.86968042 |
| 87 | Facial diplegia (HP:0001349) | 1.86192014 |
| 88 | Testicular atrophy (HP:0000029) | 1.84793017 |
| 89 | Congenital cataract (HP:0000519) | 1.81583693 |
| 90 | Waddling gait (HP:0002515) | 1.81300921 |
| 91 | Progressive muscle weakness (HP:0003323) | 1.80782949 |
| 92 | Right ventricular cardiomyopathy (HP:0011663) | 1.76761301 |
| 93 | Bundle branch block (HP:0011710) | 1.74000530 |
| 94 | Atrioventricular block (HP:0001678) | 1.73618713 |
| 95 | Knee flexion contracture (HP:0006380) | 1.72008407 |
| 96 | Lipoatrophy (HP:0100578) | 1.71474217 |
| 97 | Heart block (HP:0012722) | 1.71456305 |
| 98 | Proximal amyotrophy (HP:0007126) | 1.67419526 |
| 99 | Abnormal atrioventricular conduction (HP:0005150) | 1.65685299 |
| 100 | Generalized amyotrophy (HP:0003700) | 1.64711084 |
| 101 | Tarsal synostosis (HP:0008368) | 1.64515832 |
| 102 | * Rocker bottom foot (HP:0001838) | 1.64068747 |
| 103 | Hyperkalemia (HP:0002153) | 1.63143466 |
| 104 | Exercise-induced muscle cramps (HP:0003710) | 1.63094140 |
| 105 | Ulnar deviation of finger (HP:0009465) | 1.60772572 |
| 106 | Short palpebral fissure (HP:0012745) | 1.59898929 |
| 107 | * Vertebral fusion (HP:0002948) | 1.57382305 |
| 108 | Dilated cardiomyopathy (HP:0001644) | 1.56882977 |
| 109 | Corneal dystrophy (HP:0001131) | 1.51836004 |
| 110 | Synostosis involving bones of the feet (HP:0009140) | 1.50648847 |
| 111 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.50648847 |
| 112 | Anterior segment dysgenesis (HP:0007700) | 1.48903502 |
| 113 | Myotonia (HP:0002486) | 1.46797537 |
| 114 | Distal lower limb muscle weakness (HP:0009053) | 1.45471359 |
| 115 | Upper limb amyotrophy (HP:0009129) | 1.44268629 |
| 116 | Distal upper limb amyotrophy (HP:0007149) | 1.44268629 |
| 117 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.42576933 |
| 118 | Hypoplastic ischia (HP:0003175) | 1.41760971 |
| 119 | Sudden death (HP:0001699) | 1.40118036 |
| 120 | Abnormal auditory evoked potentials (HP:0006958) | 1.39257495 |
| 121 | Adducted thumb (HP:0001181) | 1.36431952 |
| 122 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.36040566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CG | 7.07000902 |
| 2 | MUSK | 6.79161502 |
| 3 | MOS | 5.52356257 |
| 4 | TRIB3 | 5.11796592 |
| 5 | PIM2 | 3.09769058 |
| 6 | MAPK15 | 2.59989586 |
| 7 | EEF2K | 2.48137945 |
| 8 | PKN2 | 2.40086880 |
| 9 | MAP3K10 | 2.23056207 |
| 10 | OBSCN | 2.12003448 |
| 11 | ICK | 2.01386571 |
| 12 | CCNB1 | 1.96580817 |
| 13 | MAPKAPK3 | 1.93663220 |
| 14 | PAK4 | 1.79799249 |
| 15 | MAP2K3 | 1.70660481 |
| 16 | CDK6 | 1.69216154 |
| 17 | ILK | 1.67247316 |
| 18 | DDR2 | 1.57750855 |
| 19 | MAP2K1 | 1.53720440 |
| 20 | TRPM7 | 1.49428889 |
| 21 | ROCK2 | 1.45650354 |
| 22 | TTN | 1.39526484 |
| 23 | EPHB1 | 1.38066919 |
| 24 | CDK14 | 1.31356713 |
| 25 | CDK15 | 1.29750714 |
| 26 | CDK18 | 1.23377293 |
| 27 | CDK11A | 1.22068121 |
| 28 | DYRK1B | 1.22046244 |
| 29 | LATS2 | 1.18336631 |
| 30 | PDGFRA | 1.13059627 |
| 31 | MAPK12 | 1.06657126 |
| 32 | ROCK1 | 1.04362403 |
| 33 | AKT2 | 1.03108559 |
| 34 | NME1 | 1.02536825 |
| 35 | LRRK2 | 1.01812338 |
| 36 | PTK6 | 1.00299757 |
| 37 | LATS1 | 0.94801814 |
| 38 | MAP2K6 | 0.92829866 |
| 39 | FGFR4 | 0.90759734 |
| 40 | EPHB2 | 0.90636284 |
| 41 | RIPK1 | 0.89406077 |
| 42 | PRKG1 | 0.88926311 |
| 43 | PTK2 | 0.85468258 |
| 44 | BRD4 | 0.82131204 |
| 45 | MTOR | 0.81449749 |
| 46 | PINK1 | 0.80990537 |
| 47 | MAP3K5 | 0.80263885 |
| 48 | SIK1 | 0.79381914 |
| 49 | NEK9 | 0.78565430 |
| 50 | MAPK7 | 0.73769407 |
| 51 | DAPK3 | 0.72622635 |
| 52 | DMPK | 0.71049419 |
| 53 | TLK1 | 0.68409952 |
| 54 | ZAP70 | 0.62964887 |
| 55 | MARK2 | 0.62178001 |
| 56 | WNK4 | 0.62065896 |
| 57 | MAPK11 | 0.61711681 |
| 58 | MAP2K4 | 0.59573384 |
| 59 | LIMK1 | 0.57479053 |
| 60 | SGK1 | 0.57364228 |
| 61 | RPS6KB2 | 0.56183005 |
| 62 | BCKDK | 0.54986907 |
| 63 | FLT3 | 0.53760033 |
| 64 | RAF1 | 0.53176788 |
| 65 | BLK | 0.51169678 |
| 66 | BMX | 0.49409873 |
| 67 | PDK2 | 0.48762613 |
| 68 | PRKD2 | 0.46902844 |
| 69 | MARK1 | 0.46395810 |
| 70 | PAK6 | 0.46099784 |
| 71 | TYRO3 | 0.46096098 |
| 72 | MAP3K6 | 0.42665133 |
| 73 | MELK | 0.42504697 |
| 74 | * RPS6KA3 | 0.41180222 |
| 75 | INSR | 0.40935505 |
| 76 | MAPKAPK2 | 0.39904702 |
| 77 | MAPK10 | 0.39666382 |
| 78 | ABL2 | 0.39179251 |
| 79 | STK10 | 0.38689419 |
| 80 | ABL1 | 0.36319381 |
| 81 | RPS6KB1 | 0.36191896 |
| 82 | CAMK4 | 0.35828129 |
| 83 | PRKAA2 | 0.35022064 |
| 84 | PTK2B | 0.34792961 |
| 85 | PRKACB | 0.33733728 |
| 86 | CAMK2G | 0.33555062 |
| 87 | FGFR1 | 0.33335897 |
| 88 | MAP3K13 | 0.32908875 |
| 89 | CAMK2D | 0.29852957 |
| 90 | NTRK1 | 0.29788852 |
| 91 | CDK5 | 0.29560507 |
| 92 | SGK3 | 0.29521054 |
| 93 | CAMK2A | 0.29434877 |
| 94 | PAK2 | 0.29369731 |
| 95 | FER | 0.29262403 |
| 96 | FGR | 0.28108488 |
| 97 | PHKG2 | 0.27301990 |
| 98 | PHKG1 | 0.27301990 |
| 99 | RPS6KA2 | 0.26731094 |
| 100 | MAP3K7 | 0.26635135 |
| 101 | ADRBK1 | 0.26490096 |
| 102 | PIK3CA | 0.26168333 |
| 103 | PRKACA | 0.25943222 |
| 104 | TAOK2 | 0.25920210 |
| 105 | STK11 | 0.25787782 |
| 106 | RPS6KA6 | 0.25136816 |
| 107 | CSNK1D | 0.25067152 |
| 108 | RPS6KC1 | 0.24907948 |
| 109 | RPS6KL1 | 0.24907948 |
| 110 | PRKAA1 | 0.24596929 |
| 111 | WNK1 | 0.23852683 |
| 112 | PDPK1 | 0.23277836 |
| 113 | PAK1 | 0.22794022 |
| 114 | CDK9 | 0.22729836 |
| 115 | PDGFRB | 0.21931517 |
| 116 | BMPR1B | 0.21629087 |
| 117 | ALK | 0.21542558 |
| 118 | CAMK1 | 0.21167428 |
| 119 | MET | 0.21150196 |
| 120 | KSR1 | 0.20937037 |
| 121 | STK16 | 0.20426980 |
| 122 | PKN1 | 0.20179275 |
| 123 | CDK8 | 0.18805035 |
| 124 | CAMK2B | 0.18187212 |
| 125 | MAPK4 | 0.17927238 |
| 126 | CDK4 | 0.17659973 |
| 127 | RET | 0.17168034 |
| 128 | TIE1 | 0.17137133 |
| 129 | CSNK1E | 0.17020586 |
| 130 | KSR2 | 0.16892436 |
| 131 | RPS6KA1 | 0.16756240 |
| 132 | ARAF | 0.16651855 |
| 133 | TGFBR2 | 0.16287955 |
| 134 | RPS6KA5 | 0.15762489 |
| 135 | EPHA2 | 0.15090362 |
| 136 | ERBB4 | 0.14552780 |
| 137 | CDK12 | 0.14552693 |
| 138 | MAPK8 | 0.14521437 |
| 139 | PAK3 | 0.13847970 |
| 140 | HIPK2 | 0.12846531 |
| 141 | PRKD1 | 0.12825007 |
| 142 | MAPK9 | 0.12554140 |
| 143 | CSK | 0.12442707 |
| 144 | ERBB2 | 0.12022044 |
| 145 | PRKCA | 0.11547570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 6.08058478 |
| 2 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 5.84538325 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 5.76064669 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.77876225 |
| 5 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.64328356 |
| 6 | Focal adhesion_Homo sapiens_hsa04510 | 2.63146241 |
| 7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.62017631 |
| 8 | Tight junction_Homo sapiens_hsa04530 | 2.44938406 |
| 9 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 2.07011225 |
| 10 | Viral myocarditis_Homo sapiens_hsa05416 | 1.92134435 |
| 11 | Sulfur relay system_Homo sapiens_hsa04122 | 1.88946818 |
| 12 | Adherens junction_Homo sapiens_hsa04520 | 1.81555477 |
| 13 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.75817931 |
| 14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.75681763 |
| 15 | Bladder cancer_Homo sapiens_hsa05219 | 1.67427357 |
| 16 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66611981 |
| 17 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.57788791 |
| 18 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.52083592 |
| 19 | Amoebiasis_Homo sapiens_hsa05146 | 1.47965783 |
| 20 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.28846051 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.24724645 |
| 22 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.21978911 |
| 23 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.17878647 |
| 24 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.16841015 |
| 25 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.16535248 |
| 26 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.14385894 |
| 27 | Lysine degradation_Homo sapiens_hsa00310 | 1.13490399 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05946621 |
| 29 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.05907731 |
| 30 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.05871555 |
| 31 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.04934942 |
| 32 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.04292765 |
| 33 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.03539520 |
| 34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.02598688 |
| 35 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.02064300 |
| 36 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.01973756 |
| 37 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.01679603 |
| 38 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.01313477 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.00531715 |
| 40 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.99683123 |
| 41 | Glioma_Homo sapiens_hsa05214 | 0.98619914 |
| 42 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.98584461 |
| 43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.97631424 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94782258 |
| 45 | Renin secretion_Homo sapiens_hsa04924 | 0.93375118 |
| 46 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.91907114 |
| 47 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.91297358 |
| 48 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.90828081 |
| 49 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.88225163 |
| 50 | Melanoma_Homo sapiens_hsa05218 | 0.88208207 |
| 51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87990366 |
| 52 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.86977834 |
| 53 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.85635940 |
| 54 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.84112287 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82869830 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80936354 |
| 57 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.80831021 |
| 58 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.80138755 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80117240 |
| 60 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.78994191 |
| 61 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.78864233 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77810177 |
| 63 | Axon guidance_Homo sapiens_hsa04360 | 0.77691625 |
| 64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.77554603 |
| 65 | Alcoholism_Homo sapiens_hsa05034 | 0.77232897 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75893939 |
| 67 | Prostate cancer_Homo sapiens_hsa05215 | 0.75723784 |
| 68 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75101075 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72927483 |
| 70 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.72305221 |
| 71 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71401240 |
| 72 | Melanogenesis_Homo sapiens_hsa04916 | 0.70821159 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69971346 |
| 74 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.69826203 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.69177526 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68446308 |
| 77 | Long-term potentiation_Homo sapiens_hsa04720 | 0.66827416 |
| 78 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.66785588 |
| 79 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.66772649 |
| 80 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65597467 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63328427 |
| 82 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63030380 |
| 83 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62952640 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.62510128 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61318462 |
| 86 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.61165936 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61038849 |
| 88 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.60159131 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58228804 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.57348626 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56700710 |
| 92 | Salivary secretion_Homo sapiens_hsa04970 | 0.56668929 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54054629 |
| 94 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53807133 |
| 95 | Phototransduction_Homo sapiens_hsa04744 | 0.53427320 |
| 96 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51669053 |
| 97 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51570930 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51142091 |
| 99 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50861730 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.50067387 |
| 101 | Gap junction_Homo sapiens_hsa04540 | 0.49971305 |
| 102 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.49640534 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49478293 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49235531 |
| 105 | Salmonella infection_Homo sapiens_hsa05132 | 0.47899718 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47555436 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.47171037 |
| 108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46746574 |
| 109 | Circadian entrainment_Homo sapiens_hsa04713 | 0.45255446 |
| 110 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.43544618 |
| 111 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43169858 |
| 112 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41598141 |
| 113 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.38383853 |
| 114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37503686 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37364118 |
| 116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.37125173 |
| 117 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.36856875 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36359837 |
| 119 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36297160 |
| 120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34219853 |
| 121 | Apoptosis_Homo sapiens_hsa04210 | 0.33888964 |
| 122 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33261850 |
| 123 | Thyroid cancer_Homo sapiens_hsa05216 | 0.32576122 |
| 124 | Long-term depression_Homo sapiens_hsa04730 | 0.32553767 |
| 125 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.31783474 |
| 126 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31727556 |
| 127 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.31541604 |
| 128 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31221399 |
| 129 | Hepatitis B_Homo sapiens_hsa05161 | 0.30755774 |
| 130 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.30713980 |
| 131 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30562749 |
| 132 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.30532102 |
| 133 | Endocytosis_Homo sapiens_hsa04144 | 0.30266189 |
| 134 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.30258408 |
| 135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.30115466 |
| 136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.29769083 |
| 137 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.29258944 |
| 138 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28689457 |
| 139 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28080373 |
| 140 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.27962262 |
| 141 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27935686 |
| 142 | Insulin secretion_Homo sapiens_hsa04911 | 0.27752132 |
| 143 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.27415600 |

